Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Goodwin Keeps Building In Antitrust As Inquiries Into Tech, Life Sciences Grow (Law.com)

Related Content

A Few Tenths of a Per Cent Was Enough: What Booking/Etraveli Means for Platform Deals

DOJ Announces New Fast-Track Option for Merger Reviews: What It Means for Your Deal

Caremark Settles PBM FTC Action Regarding Reimbursement Practices, Second Major PBM to Settle

Antitrust & Competition Healthcare 1H 2026 Update

Antitrust & Competition Technology 1H 2026 Update

Antitrust & Competition Life Sciences 1H 2026 Update

Goodwin’s Submission in Response to the European Commission’s Public Consultation on the Draft Guidelines Accompanying Council Regulation (EC) No 139/2004 on the Control of Concentrations Between Undertakings

White House and DOJ Gain Early Traction in Campaign Against Restrictive Hospital-Payor Contract Terms With OhioHealth Settlement

Four Goodwin Partners Named to Forbes’ 2026 Top 250 Lawyers in America List

FTC’s Deals on Drug Price Reform Have Critics Questioning Scope (Bloomberg Law)

Eight Goodwin Partners Recognized by Benchmark Litigation’s 40 and Under List 2026

Goodwin Strengthens Antitrust Platform with Addition of Margaret Webb

Competition-IP Interface: Transactions, Collaboration, and Unilateral Conduct (Practical Law)

AI on the Docket: How AI is Transforming the Practice of Antitrust Law

The Legal 500 US 2026 Recognizes 47 Goodwin Practices and 185 Lawyers

Chambers USA 2026 Recognizes a Record Number of Goodwin Practices and Lawyers for Exceptional Client Service

Technology

Life Sciences

Private Equity

Medtech

Antitrust & Competition

Mergers & Acquisitions

Complex Litigation & Dispute Resolution

Antitrust Services for Life Sciences Companies

Litigation